SCHEMBL31669155

SCHEMBL31669155

Nc1ccccc1OC(=O)N1CC[C@@H](N)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.44
▸ GAA P10253 2/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ TSHR P16473 2/20 0.38
▸ GHSR Q92847 3/20 0.38
▸ HSD11B1 P28845 1/20 0.37
▸ CHRM2 P08172 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ PARP2 Q9UGN5 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ CACNA1B Q00975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31669152 0.86 TP53 (0.44) TP53GAASMN1; SMN2ALDH1A1KDM1A
SCHEMBL31669103 0.82 TP53 (0.42) TP53GAASMN1; SMN2ALDH1A1KDM1A
SCHEMBL31669191 0.82 EPHX1 (0.46) TP53GAASMN1; SMN2ALDH1A1KDM1A
SCHEMBL31669378 0.82 RAB9A (0.52) TP53GAASMN1; SMN2ALDH1A1NPC1
SCHEMBL31669267 0.81 USP30 (0.42) SMN1; SMN2ALDH1A1HDAC1HDAC2RAB9A
SCHEMBL31669154 0.81 GAA (0.63) TP53GAASMN1; SMN2ALDH1A1KDM1A
SCHEMBL31669414 0.80 RAB9A (0.50) TP53GAASMN1; SMN2ALDH1A1KDM1A
SCHEMBL31669333 0.80 SLC6A3 (0.51) TP53GAASMN1; SMN2ALDH1A1KDM1A
SCHEMBL31669098 0.80 SMN1; SMN2 (0.41) TP53GAASMN1; SMN2ALDH1A1KDM1A
SCHEMBL31669389 0.79 SLC6A4 (0.41) TP53GAAKDM1AMAOATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors DONG-A SOCIO HOLDINGS CO., LTD. (KR) 2025-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378224-B2 Heteroaryl compounds and their use as Mer inhibitors MERTK, RET, ERBB2 TP53 816/4885GAA 1225/4885SMN1; SMN2 2563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback